Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-11T19:26:52.502Z Has data issue: false hasContentIssue false
  • English
  • Français

P0235 - The outcome of depression and cancer diseases

Published online by Cambridge University Press:  16 April 2020

D.M. Podea ,
R.M. Chenderes  and
P.D. Nanu
D.M. Podea
Affiliation:
West University Vasile Goldis Arad, Psychiatry Department, Arad, Romania
R.M. Chenderes
Affiliation:
West University Vasile Goldis Arad, Psychiatry Department, Arad, Romania
P.D. Nanu
Affiliation:
West University Vasile Goldis Arad, Neurology Department, Arad, Romania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objective:The purpose of this study is to diagnose MDD and to determine its influence to the prognostic and outcome of cancer diseases.

Material and Methods:

The study comprises 30 patients diagnosed with cancer. These patients were admitted in the Hematological Clinic of Arad during May 2006–October 2006 and were evaluated physically, psychiatric and psychological. The psychological evaluation was made with Hamilton Rating Scale for Depression (HAMD) and Global Assesment of Functioning Scale (GAFscore) at admission and after 3 weeks of antidepressant treatment.

The patients were divided into two groups:

  1. - GroupA–15patients diagnosed with MDD, that were undergoing mirtazapine;

  2. - GroupB–15 patients that were not treated with antidepressants.

Results:

The majority of the patients (n=16) were diagnosed with moderate depressive episode and only 4 patients weren't diagnose with depression. Fatigue was present to all patients included into the study while weight loss and loss of appetite were present to 16 and 12 patients. The evolution of average of HAMD scores was better in group A than in group B (5 vs.1,73). GAF score of 90-81, 80-71, 70-61 point was recorded in a higher percentage in the patients of group A.

Conclusions:

Patients with cancer have a high rate of MDD.

MDD is a negative prognostic factor for cancer diseases. It influences and modifies the prognostic of disease.

Type
Poster Session II: Depression
Information
European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S261 - S262
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.